Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors

Detalles Bibliográficos
Autores principales: Kori, S, Zhang, J, Kellerman, D, Armer, T, Goadsby, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620485/
http://dx.doi.org/10.1186/1129-2377-14-S1-P75
_version_ 1782265607685668864
author Kori, S
Zhang, J
Kellerman, D
Armer, T
Goadsby, P
author_facet Kori, S
Zhang, J
Kellerman, D
Armer, T
Goadsby, P
author_sort Kori, S
collection PubMed
description
format Online
Article
Text
id pubmed-3620485
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-36204852013-09-20 Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors Kori, S Zhang, J Kellerman, D Armer, T Goadsby, P J Headache Pain Poster Presentation Springer 2013 2013-02-21 /pmc/articles/PMC3620485/ http://dx.doi.org/10.1186/1129-2377-14-S1-P75 Text en Copyright ©2013 Kori et al; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Kori, S
Zhang, J
Kellerman, D
Armer, T
Goadsby, P
Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title_full Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title_fullStr Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title_full_unstemmed Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title_short Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
title_sort sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-ht1b and 5-ht1d receptors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620485/
http://dx.doi.org/10.1186/1129-2377-14-S1-P75
work_keys_str_mv AT koris sustainedpainreliefwithdihydroergotamineinmigraineispotentiallyduetopersistentbindingto5ht1band5ht1dreceptors
AT zhangj sustainedpainreliefwithdihydroergotamineinmigraineispotentiallyduetopersistentbindingto5ht1band5ht1dreceptors
AT kellermand sustainedpainreliefwithdihydroergotamineinmigraineispotentiallyduetopersistentbindingto5ht1band5ht1dreceptors
AT armert sustainedpainreliefwithdihydroergotamineinmigraineispotentiallyduetopersistentbindingto5ht1band5ht1dreceptors
AT goadsbyp sustainedpainreliefwithdihydroergotamineinmigraineispotentiallyduetopersistentbindingto5ht1band5ht1dreceptors

Ejemplares similares